AGL 40.00 Decreased By ▼ -0.03 (-0.07%)
AIRLINK 128.15 Increased By ▲ 0.45 (0.35%)
BOP 6.68 Increased By ▲ 0.07 (1.06%)
CNERGY 4.51 Decreased By ▼ -0.09 (-1.96%)
DCL 9.15 Increased By ▲ 0.36 (4.1%)
DFML 41.80 Increased By ▲ 0.22 (0.53%)
DGKC 87.50 Increased By ▲ 1.71 (1.99%)
FCCL 32.68 Increased By ▲ 0.19 (0.58%)
FFBL 64.50 Increased By ▲ 0.47 (0.73%)
FFL 11.61 Increased By ▲ 1.06 (10.05%)
HUBC 111.50 Increased By ▲ 0.73 (0.66%)
HUMNL 14.75 Decreased By ▼ -0.32 (-2.12%)
KEL 5.06 Increased By ▲ 0.18 (3.69%)
KOSM 7.43 Decreased By ▼ -0.02 (-0.27%)
MLCF 41.04 Increased By ▲ 0.52 (1.28%)
NBP 61.30 Increased By ▲ 0.25 (0.41%)
OGDC 195.57 Increased By ▲ 0.70 (0.36%)
PAEL 27.75 Increased By ▲ 0.24 (0.87%)
PIBTL 7.77 Decreased By ▼ -0.04 (-0.51%)
PPL 153.01 Increased By ▲ 0.48 (0.31%)
PRL 26.57 Decreased By ▼ -0.01 (-0.04%)
PTC 16.20 Decreased By ▼ -0.06 (-0.37%)
SEARL 84.27 Increased By ▲ 0.13 (0.15%)
TELE 7.91 Decreased By ▼ -0.05 (-0.63%)
TOMCL 36.68 Increased By ▲ 0.08 (0.22%)
TPLP 8.88 Increased By ▲ 0.22 (2.54%)
TREET 17.11 Decreased By ▼ -0.55 (-3.11%)
TRG 57.44 Decreased By ▼ -1.18 (-2.01%)
UNITY 27.00 Increased By ▲ 0.14 (0.52%)
WTL 1.34 Decreased By ▼ -0.04 (-2.9%)
BR100 10,000 No Change 0 (0%)
BR30 31,002 No Change 0 (0%)
KSE100 94,800 Increased By 607.6 (0.65%)
KSE30 29,447 Increased By 246 (0.84%)

A non-prescription hormonal supplement sometimes marketed as a "fountain of youth" drug may be effective in combating mid-life depression, doctors said on Monday. The drug DHEA - dehydroepiandrosterone - "may have a useful role in the treatment of mild to moderately severe midlife-onset major and minor depression" in some patients, said the report from the National Institute of Mental Health.
The findings were based on a small study involving 46 men and women aged 45 to 65 who had major or minor depression of moderate severity.
Some were given the drug and others an inert placebo, and the process was repeated switching the drug and no-drug groups. At the end the participants were measured by standard tests for depression.
In all, 23 showed a reduction of at least 50 percent in their depression after they received the drug. In addition, 13 showed improvement after the placebo.
The report was published in the Archives of General Psychiatry.
The authors said since only half of those studied found improvement with the drug and it is not clear why or for whom it best works, a more conventional anti-depression drug would likely the first choice for treatment.

Copyright Reuters, 2005

Comments

Comments are closed.